Category:
Active Pharmaceutical Ingredients
CAS NO:
NA
Standard:
In-house Standards,
Relugolix is an oral small-molecule GnRH receptor antagonist used in hormone therapy. Its core synthesis involves complex organic coupling to yield the specific structure C28H35N7O6S (CAS: 1049953-59-2).
Contraindicated in pregnancy due to fetal harm risks. Requires strict temperature control at 25°C during storage. Monitor for QT prolongation and bone mineral density loss in long-term clinical use.